Research Projects & Grants

For Profit Organization

  • A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis, Role: Principal Investigator, Shire Pharmaceuticals, Status: Awarded
  • A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis, Role: Principal Investigator, Shire Pharmaceuticals, Status: Closed
  • (CDA) Lexitas Pharma Services / Dr. John Affeldt, Role: PD/PI, Lexitas Pharma Services, Inc., Status: Awarded
  • A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group, Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Stage 2 and 3 Neurotrophic Keratitis Subjects, Role: PD/PI, Claris Biotherapeutics, Status: Awarded
  • A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of the KXL System with VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes with Keratoconus or Corneal Ectasia after Refractive Surgery, Role: Principal Investigator, Avedro, Inc., (04/2013 - 04/2014) Status: Closed